Vioxx (rofecoxib) just got approved in the U.S. for migraines and Health Canada is considering the same

Vioxx (rofecoxib) just got approved in the U.S. for migraines and Health Canada is considering the same.

It's the first COX-2 inhibitor approved for this use.

This is not a surprise.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote